Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

July 1, 2022

Popular Minecraft Creator and YouTuber, Technoblade, Dies of Rare Cancer, ‘General Hospital’ Star Discusses Life After Cancer and More

Author(s):

Brielle Benyon

From “General Hospital” star Cameron Mathison discussing his cancer experience to Dame Deborah James and Hells Angels founder Sonny Barger dying of the disease, here’s what happened in the cancer space this week.

Popular Minecraft player and YouTuber, Technoblade, dies of cancer.

Technoblade’s family confirmed the news on his YouTube channel to his more than 11 million followers.

He began uploading Minecraft videos to YouTube in 2013 but didn’t become popular until 2019 when he won multiple tournaments related to the game. Technoblade, 23, announced his cancer diagnosis in August 2021. He had previously recalled how he started experiencing pain in his right arm. Soon after his shoulder began to swell, and he went to the hospital.

The diagnosis was stage 4 sarcoma, a rare form of cancer that begins in the bones and soft tissue.

“This past year has had a lot of rough spots for our son as he battled stage four cancer. But he didn’t complain and kept using his famous strategic mind to try to beat what he knew were almost impossible odds,” Technoblade’s family said in a statement. “My son’s bravery on this path was a shining lesson to all of us who were privileged to walk it with him. Thank you for sharing his journey through it all, as he did the work he loved for his beloved fans.”

“General Hospital” star Cameron Mathison opens up about life after cancer.

Cameron Mathison, who is known for his role as Drew Cain on the soap opera “General Hospital,” underwent surgery for kidney cancer in 2019. More recently, at the 49th annual Daytime Emmy Awards, the 52-year-old actor opened up about his cancer, and what life has been like ever since.

“(My cancer has) increased my desire and my willingness and my effort and motivation to help others and to spread the word and just to be a benefit," he told PEOPLE. "I work with a health coach now — I thought I knew a lot about what I was doing in the right and the wrong ways or whatever, but in the last year, I'd say, maybe 14 months, I've learned more about my own specific health challenges and growth than I have probably in decades before that."

Hells Angels co-founder and former president dies of cancer.

Sonny Barger, who founded the Oakland, California, chapter of the notorious motorcycle club, Hells Angels, died this week after being diagnosed with stage 4 liver cancer.

A Facebook post on the 83-year-old’s page read, “If you are reading this message, you’ll know that I’m gone. I’ve asked that this note be posted immediately after my passing. I’ve lived a long and good life filled with adventure. And I’ve had the privilege to be part of an amazing club. Although I’ve had a public persona for decades, I’ve mostly enjoyed special time with my club brothers, my family, and close friends. Please know that I passed peacefully after a brief battle with cancer.”

Barger’s involvement with the Hells Angels started in 1957, when he launched the Oakland chapter of the club. He then moved on to become the national president when the former president went to prison. His tenure as president was then also cut short by his arrest.

British broadcaster and cancer campaigner, Deborah James, dies of cancer.

Dame Deborah James, host of the BBC podcast, “You Me and the Big C,” which featured an honest look at her life with bowel cancer, died from the disease at the age of 40.

Over the years, James has raised millions of dollars for cancer research, garnering the attention of Prince William, who granted James damehood in a surprise visit while she was receiving hospice care.

“We are so sad to hear the heartbreaking news about Dame Deborah. Our thoughts are with her children, her family and her loved ones,” Prince William and his wife, Kate, said in a tweet. “Deborah was an inspirational and unfalteringly brave woman whose legacy will live on.”

Comedian Tig Notaro reflects on how her breast cancer diagnosis — and sharing it with the world — shaped her career.

Ten years ago, Tig Notaro walked on stage and started her set with, “Hello. I have cancer.”Now, she recently discussed how those words changed her life, and related that time to the COVID-19 pandemic, which helped some people get a clearer definition of who they were.

“It’s funny because with the pandemic, everybody always talks about pre-pandemic and post-pandemic, and I’m very much similar around that time period, where you’re always getting to know yourself,” Notaro said on the “Hello Monday” podcast. “But I feel like I really didn’t know myself on a whole other level before 2012.”

Notaro said that in retrospect, she has no regrets about going public with her breast cancer, and that she would do it all over again.

“Since that time period, I've been on a mission to feel good in my headspace, my body the company that I keep, the decisions I make, all of it. I want to feel good and that's not just me being selfish … with comedy if I have to think it's funny. For me to enjoy being there, which is going to hopefully in turn, make the audience feel that way. So it's similar in that I want to feel good,” she said.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with black hair.
Investigating the Addition of Surgery to ICI Therapy in Kidney Cancer
Picture of Dr. Pouneh Razavi
Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients
Image of Kumar.
Raising Awareness on Multidisciplinary Approaches in GI Cancers
Image of Dr. Uboha.
Understanding Esophageal Cancer: Early Signs, Risks and Key Insights
Image of Dr. Kumar.
Radiation Therapy Advances Improve Quality of Life for GI Cancer
Image of a woman wearing a headband and glasses
An Expert Breaks Down Lymphedema Following Cancer Care
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Raising Awareness for Kidney Cancer and the Challenges Patients Face
Image of doctor.
Shorter Radiation Courses May Improve Breast Reconstruction Outcomes
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment
Related Content
Advertisement
Image of kidneys.
May 27th 2025

Dose Escalation Complete in Kidney Cancer Trial of HC-7366 Plus Welireg

Ryan Scott
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
HEATHER PATENAUDE, B.S.N., RN
May 23rd 2025

True Grit: The Spirit of an Extraordinary Healer

Pamela O’Neil,M.S.N.,NP-C,AOCNP
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Itovebi plus Ibrance and Faslodex improved overall survival in patients with HR+, HER2– breast cancer versus placebo: © stock.adobe.com.
May 22nd 2025

Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

Caroline Seymour
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Felicia Mitchell is a survivor of stage 2b HER2-positive breast cancer diagnosed in 2010. Catch up on all of Felicia's blogs here!
May 22nd 2025

Contemplating AI Assistance as a Cancer Survivor

Felicia Mitchell
When I saw a study about using AI facial recognition in cancer decision-making headlines, I decided to try my own informal, non-scientific experiment.
Related Content
Kidney CancerLiver CancerGastrointestinal CancersBreast Cancer
Kidney Cancer
|
Liver Cancer
|
Gastrointestinal Cancers
|
Breast Cancer
Advertisement
Image of kidneys.
May 27th 2025

Dose Escalation Complete in Kidney Cancer Trial of HC-7366 Plus Welireg

Ryan Scott
A phase 1b study of HC-7366 plus Welireg for advanced clear cell renal cell carcinoma has completed the dose escalation portion of the clinical trial.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
HEATHER PATENAUDE, B.S.N., RN
May 23rd 2025

True Grit: The Spirit of an Extraordinary Healer

Pamela O’Neil,M.S.N.,NP-C,AOCNP
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Itovebi plus Ibrance and Faslodex improved overall survival in patients with HR+, HER2– breast cancer versus placebo: © stock.adobe.com.
May 22nd 2025

Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer

Caroline Seymour
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Felicia Mitchell is a survivor of stage 2b HER2-positive breast cancer diagnosed in 2010. Catch up on all of Felicia's blogs here!
May 22nd 2025

Contemplating AI Assistance as a Cancer Survivor

Felicia Mitchell
When I saw a study about using AI facial recognition in cancer decision-making headlines, I decided to try my own informal, non-scientific experiment.
Advertisement
Advertisement
Advertisement
x
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.